Pay in 4 interest-free payments of $6.85 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Para continuar, ingresa atu cuenta trace-id: aa6c1785-c2cb-4b8f-8d94-bcb6d232f4d7 Usamos cookies para mejorar tu experiencia en Mercado Libre
The intended demographic is people with type 2 diabetes, but off-label use can result in weight loss
Informed Consent At minimum, discuss: Expected weight loss (typically 10-15% body weight with GLP-1s over 6-12 months) Side effects (GI upset with GLP-1s, insomnia/tachycardia with phentermine) Off-label use if applicable (e.g., prescribing Ozempic for obesity when Wegovy is the approved versionsome states like Mississippi prohibit this) Need for lifestyle changes (medication alone wont work) Follow-up schedule Document the conversation in the chart
Discussion The idea of GSH-induced hypopigmenta-tion may stem from early studies linking sulfhydral-containing compounds to the inhibition of melanogenesis or from early anecdotal observations in Parkinson's disease
A detailed description of [ 68 Ga]Ga-DO3A-Tuna-2 biodistribution including kinetic analysis and dosimetry is outside the scope of the current manuscript and will be reported separately
